| scholarly article | Q13442814 |
| P2093 | author name string | Sana D Karam | |
| Cathy J Bradley | |||
| Rustain L Morgan | |||
| P2860 | cites work | Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis | Q26771327 |
| Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study | Q30500194 | ||
| Development of a comorbidity index using physician claims data | Q30623996 | ||
| Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer | Q35783387 | ||
| Implicit bias in healthcare professionals: a systematic review | Q36294450 | ||
| Impact of care at comprehensive cancer centers on outcome: Results from a population-based study | Q36967563 | ||
| Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers | Q37103058 | ||
| Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients | Q37251554 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| How generalizable are the SEER registries to the cancer populations of the USA? | Q39575585 | ||
| Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology | Q40244899 | ||
| Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer | Q40426764 | ||
| Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. | Q43972336 | ||
| Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. | Q44701810 | ||
| National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery | Q45713581 | ||
| Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics | Q46210264 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Lung Cancer Health Disparities. | Q53177073 | ||
| Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q57051777 | ||
| NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018 | Q90101749 | ||
| External Determinants of Veterans' Utilization of VA Health Care | Q90657228 | ||
| Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS | Q90823982 | ||
| Implicit Bias Education and Emergency Medicine Training: Step One? Awareness | Q91213820 | ||
| Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients? | Q91524006 | ||
| ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer | Q91758637 | ||
| P577 | publication date | 2020-03-05 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Ethnic Disparities in PET/CT Utilization at Diagnosis of Non-Small Cell Lung Cancer |
| Q99234116 | Cancer health disparities in racial/ethnic minorities in the United States |
| Q98226198 | Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis |
| Q90062859 | Use of PET Imaging: Another Non-Biological Source of Racial Disparities in US Cancer Care |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.